Havana Conference Center, Varadero, Cuba, from 25 to junio 29, 2017
Home / Invitation

Main Topics


Workshop on Immunopharmacology

  • Living drugs: Chimeric Antigen Receptor (CAR)-T cells, Immunocheckpoints,
  • Basic Immunopharmacology: New therapeutic targets, new technologies and approaches
  • Inflammation. Molecular basis
  • Inflammation and Pain
  • Autoimmune diseases and therapeutic strategies
  • Allergy and hypersensitivity
  • Tumour Immunity
  • Transplantation
  • Immunological tolerance
  • Immunodeficiency
  • Immunosenescense
  • Immunotherapy and Immunomodulation
  • OMICS: Genomics, Proteomics and Pharmacogenomics

Workshop on Neuroimmunopharmacology
Workshop on Neuroimmunopharmacology Neuroimmunology and Neuropharmacology: Immune cells in neuroimmunological disorders,Psychoneuroimmunology,Neuroinflammation, Biomarkers of neuroinflammation and neuroregeneration, Personalized neuroimmunology, The microbiome in neuroimmunological diseases, Immune rebalancing and immunotherapeutic strategies, Novel development and applications of nanotechnology for Neuroimmunology, Stroke and immune system, Multiple Sclerosis and others autoimmune diseases of CNS, Immunopathogenesis of Neurodegenerative diseases:  Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis .Relevant targets and translational research on neuroimmunological disorders

Symposium on Cytochrome P 450
Pharmacogenetic. Cytochrome P 450, Drug transporters, regulation and inflammation. Pharmacological interactions.

Preclinical and clinical evaluation of biological products (blood products, monoclonal antibodies, cytokines, grow factors and immunological stimulators)


Workshop on Prophylactic vaccines

  • Landscape on Prophylactic Vaccination: Regulatory issues and vaccine market trends, Health policies and immunization programs, Safety studies, ethic issues and public acceptance
  • Vaccines against Infectious Diseases: Anti-Viral, Bacterial, Parasites vaccines. Conjugated and combined vaccines.
  • Emerging and re-emerging infectious disease vaccines.
  • Adult vaccination.
  • Development of Vaccine Clinical Trials
  • Vaccine Production, Manufacturing and QC/QA: New approaches in Vaccine Technology, Regulatory issues, 3Rs Alternatives for current Potency and Safety testing
  • Pharmacovigilance. Immune-epidemiological studies
  • Vaccine Technology
  • Bioprocesses issues

Workshop on Therapeutic vaccines

Experimental and Clinical Evaluation of Therapeutic Vaccines for Cancer and other non-infectious chronic diseases: Validation of novel targets, Optimization of treatment strategies, Immune response monitoring, Innovative combination of vaccines, Genetic and immunological predictors of response, Clonal exhaustion and long-term vaccination, Vaccination and aging, Clinical trials

Maladaptive responses to retained apoB-lipoproteins. How the different members of the lipoprotein family contribute to the atherogenic process. Role of proteoglycans and other components of the arterial wall in the different stages of atherosclerosis development. Oxidative stress and atherogenesis. Role of innate and adaptive immune system in atherogenesis. Atherosclerosis and cardiovascular diseases. Atherosclerosis and endocrine diseases. Development of new therapeutic strategies

Approaches to engineering vectors and cells; Manufacturing of gene and cell therapy products; Clinical trials; Regenerative Medicine; Lessons learned: cancer, inflammatory and autoimmune diseases, infectious diseases, etc.; Patients perspectives; Regulatory strategies.

Genome-wide Functions of NF-kB subunits; Regulation of NF-κB subunits by PTMs;Crosstalk of NF-κB subunits with others systems; NF-κB in stress response & Cancer;NF-κB in growth control and Cancer